A detailed history of Pdt Partners, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 175,239 shares of PTCT stock, worth $6.16 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
175,239
Previous 175,507 0.15%
Holding current value
$6.16 Million
Previous $4.84 Million 5.4%
% of portfolio
0.51%
Previous 0.55%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$24.15 - $31.95 $6,472 - $8,562
-268 Reduced 0.15%
175,239 $5.1 Million
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $2.01 Million - $3.26 Million
111,112 Added 172.55%
175,507 $4.84 Million
Q3 2023

Nov 14, 2023

BUY
$22.41 - $41.99 $33,121 - $62,061
1,478 Added 2.35%
64,395 $1.44 Million
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $1,898 - $2,777
-47 Reduced 0.07%
62,917 $2.56 Million
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $2,633 - $3,371
69 Added 0.11%
62,964 $3.05 Million
Q4 2022

Feb 14, 2023

SELL
$33.53 - $54.79 $257,644 - $421,006
-7,684 Reduced 10.89%
62,895 $2.4 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $1.11 Million - $1.42 Million
-26,452 Reduced 27.26%
70,579 $3.54 Million
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $78,387 - $138,494
3,062 Added 3.26%
97,031 $3.89 Million
Q1 2022

May 16, 2022

BUY
$33.33 - $44.6 $3.13 Million - $4.19 Million
93,969 New
93,969 $3.51 Million
Q1 2019

May 15, 2019

SELL
$28.09 - $39.49 $7.8 Million - $11 Million
-277,609 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$29.83 - $46.51 $357 - $558
-12 Reduced -0.0%
277,609 $9.53 Million
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $678 - $955
20 Added 0.01%
277,621 $13 Million
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $25 - $47
1 Added 0.0%
277,601 $9.36 Million
Q1 2018

May 15, 2018

BUY
$17.46 - $32.59 $4.85 Million - $9.05 Million
277,600 New
277,600 $7.51 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.51B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.